|
|
|
-
Wednesday, April 09, 2025
7:52:42 PM
|
|
 |
|
|
Medicine
Healthcare & Pharm
|
|
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day
Dec 04, 2024 14:30 HKT |  | | Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Dec 04, 2024 11:08 HKT |  | | China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
Dec 02, 2024 21:30 HKT |  | | Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong
Dec 02, 2024 10:34 HKT | | | Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate
Nov 30, 2024 21:08 HKT |  | | Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC
Nov 30, 2024 20:34 HKT | | | NEFECON(R) Included in National Reimbursement Drug List (NRDL)
Nov 29, 2024 10:48 HKT | | | Kingworld-Longde Life and Health Industrial Park Grand Opening
Nov 27, 2024 14:48 HKT |  | | S&P Acknowledges Fosun's Return to the USD Bond Market
Nov 26, 2024 13:30 HKT | | | Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT |  | | JBM Healthcare Announces FY2025 Interim Results
Nov 19, 2024 20:51 HKT |  | | Everest Medicines Announces NEFECON(R)'s Full Approval in South Korea
Nov 19, 2024 17:37 HKT | | | Beat The Silent Disease of Osteoporosis with LAC, Before It's Too Late!
Nov 18, 2024 13:00 HKT | | | JBM Healthcare Issues Positive Profit Alert
Nov 04, 2024 15:00 HKT | | | Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
Oct 29, 2024 20:16 HKT |  | | TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank
Oct 29, 2024 17:30 HKT |  | | Everest Medicines Announces the Launch of VELSIPITY(R) in the Guangdong-Hong Kong-Macau Greater Bay Area
Oct 25, 2024 11:28 HKT | | | Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
Oct 25, 2024 09:18 HKT | | | HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024
Oct 25, 2024 08:57 HKT |  | | Stable S&P rating supports Fosun's globalization and innovation
Oct 23, 2024 15:43 HKT | | |
|
<< Previous
Next >>
|
|
|
| Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
Connect With us:
|
|